<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Eaton Vance Tax Advantaged Dividend Income Closed Fund — News on 6ix</title>
    <link>https://6ix.com/company/eaton-vance-tax-advantaged-dividend-income-closed-fund</link>
    <description>Latest news and press releases for Eaton Vance Tax Advantaged Dividend Income Closed Fund on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 01 Apr 2026 05:50:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/eaton-vance-tax-advantaged-dividend-income-closed-fund" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835654e78dffbe2df0f0063.webp</url>
      <title>Eaton Vance Tax Advantaged Dividend Income Closed Fund</title>
      <link>https://6ix.com/company/eaton-vance-tax-advantaged-dividend-income-closed-fund</link>
    </image>
    <item>
      <title>Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer</title>
      <link>https://6ix.com/company/eaton-vance-tax-advantaged-dividend-income-closed-fund/news/evotec-appoints-dr-ashiq-h-khan-as-chief-commercial-officer-2</link>
      <guid isPermaLink="true">https://6ix.com/company/eaton-vance-tax-advantaged-dividend-income-closed-fund/news/evotec-appoints-dr-ashiq-h-khan-as-chief-commercial-officer-2</guid>
      <pubDate>Wed, 01 Apr 2026 05:50:00 GMT</pubDate>
      <description>HAMBURG, DE / ACCESS Newswire / April 1, 2026 / Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) today announced the appointment of Dr. Ashiq H. Khan as EVP Global Head, Chief Commercial Officer. Dr. Khan brings to Evotec over 15 years of international ...</description>
    </item>
    <item>
      <title>Just - Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses</title>
      <link>https://6ix.com/company/eaton-vance-tax-advantaged-dividend-income-closed-fund/news/just-evotec-biologics-enters-project-agreement-with-barda-to-optimize-biomanufacturing-of-antibodies-against-ebola-and-related-viruses</link>
      <guid isPermaLink="true">https://6ix.com/company/eaton-vance-tax-advantaged-dividend-income-closed-fund/news/just-evotec-biologics-enters-project-agreement-with-barda-to-optimize-biomanufacturing-of-antibodies-against-ebola-and-related-viruses</guid>
      <pubDate>Mon, 23 Mar 2026 07:10:00 GMT</pubDate>
      <description>The program leverages Just - Evotec Biologics&apos; advanced biomanufacturing platform to deliver high-quality, scalable, cost-efficient production through significantly higher yields Manufacturing process development strengthens U.S. government response ...</description>
    </item>
    <item>
      <title>Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation</title>
      <link>https://6ix.com/company/eaton-vance-tax-advantaged-dividend-income-closed-fund/news/evotec-receives-dollar10-m-milestone-from-bristol-myers-squibb-protein-degradation-collaboration-for-clinical-study-initiation</link>
      <guid isPermaLink="true">https://6ix.com/company/eaton-vance-tax-advantaged-dividend-income-closed-fund/news/evotec-receives-dollar10-m-milestone-from-bristol-myers-squibb-protein-degradation-collaboration-for-clinical-study-initiation</guid>
      <pubDate>Thu, 19 Mar 2026 06:50:00 GMT</pubDate>
      <description>Dosing of first patient initiates Phase 1 clinical evaluation of BMS-986506 for the treatment of advanced clear cell renal cell carcinoma, the most common form of kidney cancer Transformative moment in strategic protein degradation collaboration with ...</description>
    </item>
    <item>
      <title>Eaton Vance Closed-End Funds Release Estimated Sources of Distributions</title>
      <link>https://6ix.com/company/eaton-vance-tax-advantaged-dividend-income-closed-fund/news/eaton-vance-closed-end-funds-190000089-4</link>
      <guid isPermaLink="true">https://6ix.com/company/eaton-vance-tax-advantaged-dividend-income-closed-fund/news/eaton-vance-closed-end-funds-190000089-4</guid>
      <pubDate>Fri, 30 Jan 2026 19:00:00 GMT</pubDate>
      <description>BOSTON, January 30, 2026--The Eaton Vance closed-end funds listed below released today the estimated sources of their January distributions (each a &quot;Fund&quot;). This press release is issued as required by the Funds’ managed distribution plan (Plan) and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly, as noted below, cash distributions to common shareholders, stated in terms of a fixed amou</description>
    </item>
  </channel>
</rss>